• Jiawei Weijin Decoction Targets SPP1 to Inhibit NSCLC Metast

  2026-08-01

  Xu et al. elucidate the anti-metastatic mechanism of Jiawei Weijin Decoction (JWWJD) in non-small cell lung cancer (NSCLC) through an integrated approach combining network pharmacology, transcriptomics, and experimental validation. Their findings reveal that curcumol, the decoction’s active component, directly targets SPP1, suppressing tumor progression and offering a promising alternative therapeutic strategy.

• Selective β1 Blockade Preserves Hematopoietic Recovery Post-

  2026-07-31

  This study demonstrates that nonselective β-adrenergic blockers impair hematopoietic regeneration after hematopoietic cell transplantation (HCT), whereas β1-selective agents like metoprolol do not. The findings highlight critical distinctions in adrenergic signaling relevant for post-transplant recovery and inform the rational design of cardiovascular and hematopoietic research protocols.

• Nanomedicine-Driven Pyroptosis and Immunotherapy in Colorect

  2026-07-31

  This study introduces a calcium lactate nanoparticle system co-delivering bufalin and CRISPR/Cas9 RNPs, enabling synergistic induction of cancer cell death and immune activation in colorectal cancer. The approach reprograms tumor-associated macrophages and edits CD47 to overcome immune evasion, pointing to a promising new direction for immunotherapy.

• Stable Isotope-Diluted UHPLC–MS/MS for Methylated Purine Nuc

  2026-07-30

  Zhang et al. present a robust stable isotope-diluted UHPLC–MS/MS method for precise quantification of ten methylated purine nucleosides, enabling improved detection of modified nucleosides in complex cellular matrices. This advance supports more accurate metabolomic profiling and biomarker discovery in RNA modification and purine metabolism research.

• Busulfan in Translational Research: Mechanistic Insight and

  2026-07-30

  This thought-leadership article explores how Busulfan, a DNA alkylating agent, enables rigorous modeling of cellular senescence and germ cell depletion for advanced translational research. Integrating mechanistic insights, experimental best practices, and strategic recommendations, it contextualizes Busulfan’s role against recent breakthroughs in lineage tracing and reproductive biology, while offering actionable guidance for maximizing experimental rigor and interpretability.

• miR-519d-3p in Placental Exosomes Drives Immune Imbalance in

  2026-07-29

  This study reveals that miR-519d-3p, delivered via placenta-derived exosomes, modulates T cell fate by enhancing proliferation, suppressing apoptosis, and skewing Th17/Treg differentiation. These findings clarify a molecular mechanism underlying immune intolerance in preeclampsia, offering a platform for further research into targeted interventions.

• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Precisi

  2026-07-29

  Sulfo-Cy3 NHS Ester enables robust, water-soluble fluorescent labeling of proteins and peptides, supporting advanced vascular biology and cell tracking. Its unique properties overcome common pitfalls in low-solubility and denaturation-prone targets, empowering researchers with high signal integrity and workflow flexibility.

• IGF2BP1–THBS1 Axis Drives Macrophage Glycolysis in Pulmonary

  2026-07-28

  The referenced study elucidates how the m6A reader protein IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA, thereby enhancing macrophage glycolytic metabolism and fibrotic polarization. This newly defined IGF2BP1/THBS1/TLR4 regulatory axis reveals potential therapeutic targets and provides a mechanistic bridge between RNA modification, macrophage function, and fibrotic disease progression.

• HyperFluor™ 594 Goat Anti-Rabbit IgG: Reliable Detection in

  2026-07-28

  This article addresses real-world challenges in cell-based immunoassays and illustrates how the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody (SKU K3305) enhances reproducibility and sensitivity. Drawing on validated protocols and experimental scenarios, it guides biomedical researchers in leveraging this affinity-purified, fluorophore-conjugated secondary antibody for robust results across ICC/IF, IHC, flow cytometry, and ELISA.

• β-Blocker Selectivity and Hematopoietic Regeneration Post-HC

  2026-07-27

  This study reveals that only nonselective β-adrenergic inhibitors, not β1-selective agents like Metoprolol Tartrate, impair hematopoietic regeneration following stem cell transplantation. The findings have direct implications for the clinical management of β-blocker therapy in patients undergoing hematopoietic cell transplants, suggesting the importance of receptor selectivity in both experimental and clinical settings.

• Advancing Synaptic Transmission Research with CGP 55845 Hydr

  2026-07-27

  This thought-leadership article empowers translational neuroscientists to dissect GABAB-mediated synaptic mechanisms using CGP 55845 hydrochloride, a highly selective GABAB receptor antagonist. Integrating mechanistic insights from cutting-edge astrocyte research, it guides experimental design, highlights protocol best practices, and contextualizes the compound’s unique role in unraveling cognitive pathways within the dentate gyrus. The piece bridges recent glial discoveries with practical assay optimization and carves out new conceptual space beyond traditional product pages.

• Applied Workflows with EZ Cap™ Human PTEN mRNA (ψUTP) in Can

  2026-07-26

  EZ Cap™ Human PTEN mRNA (ψUTP) enables robust, immune-silent PTEN re-expression in mammalian systems, uniquely positioning it for translational oncology and drug resistance studies. Its pseudouridine modification and Cap 1 structure deliver superior mRNA stability and PI3K/Akt pathway inhibition, supporting reproducible, high-impact workflows in advanced cancer research.

• Rosiglitazone (Brl-49653): Precision Tools for Adipose Brown

  2026-07-25

  Explore the advanced applications of Rosiglitazone (Brl-49653) in adipose tissue browning and metabolic assay innovation. This article uniquely connects mechanistic insight with practical protocol choices, offering a new depth for type II diabetes research.

• p-Cresyl Sulfate Drives Aortic Valve Calcification via Kloth

  2026-07-24

  This study uncovers how p-cresyl sulfate, a uremic toxin, directly enhances calcification of aortic valvular interstitial cells by downregulating klotho and SIRT1 signaling. These findings provide mechanistic insight into cardiovascular risk in chronic kidney disease and highlight potential therapeutic targets for calcific aortic valve disease.

• Single-Dose Indometacin Sodium for Acute Postoperative Pain

  2026-07-24

  This Cochrane review rigorously evaluates the efficacy and safety of single-dose oral indometacin sodium for treating acute postoperative pain. The analysis provides critical quantitative insights into pain reduction outcomes, informing best practices for NSAID use in clinical pain management and experimental research.

446 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page